In addition, miR-200c could enhance granulocyte-macrophage colony-stimulating factor (GM-CSF)-mediated M1 macrophage polarization to inhibit the growth of mouse breast cancer Met-1 cells (71). The gene discussed is CSF2; the disease is breast carcinoma.